Literature DB >> 24615610

Prognostic factors of patients with thymic carcinoma after surgery: a retrospective analysis of 58 cases.

Shuai Wang1, Zhou Wang, Xiangyan Liu, Dong Wang, Fanying Liu.   

Abstract

BACKGROUND: Thymic carcinoma is reputed to carry a poor prognosis. Although few scholars have studied the prognosis of thymic carcinoma, the prognostic factors of patients after surgery are not well established. We analyze the prognostic significance of undetermined factors to predict the survival of patients after surgery.
METHODS: We reviewed 351 cases of thymic epithelial tumor treated with surgery at a single institution in China from 1992 to 2011. A total of 58 patients were histopathologically reconfirmed as having thymic carcinoma. Clinicopathological characteristics and treatment modalities were reviewed. During the follow-up, with a median of 65.8 months, survival time was analyzed using the Kaplan-Meier method. Univariate and multivariate analysis were performed to identify prognostic factors.
RESULTS: The overall 3-, 5-, and 10-year survival rate was 69.0, 43.1, and 12.1%, respectively. The Log-rank test revealed that Masaoka stage (p = 0.000), histology group (p = 0.000), completeness of the resection (p = 0.000), great vessel invasion (p = 0.000), and presence of symptoms (p = 0.003) were significant prognostic factors in all patients. However, tumor size (p = 0.086), age (p = 0.677), sex (p = 0.706), smoking (p = 0.065), and alcohol (p = 0.875) were not prognostic factors. A Cox proportional hazards regression model showed that Masaoka stage (hazard ratio = 15.640, p = 0.000) and completeness of the resection (hazard ratio = 18.303, p = 0.000) were the only independent prognostic factors.
CONCLUSIONS: The Masaoka stage and completeness of the resection were independent prognostic factors that predicted long-term survival of patients with thymic carcinoma treated with surgery.

Entities:  

Mesh:

Year:  2014        PMID: 24615610     DOI: 10.1007/s00268-014-2492-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  21 in total

Review 1.  Thymic carcinoma--analysis of nineteen clinicopathological studies.

Authors:  D A Chung
Journal:  Thorac Cardiovasc Surg       Date:  2000-04       Impact factor: 1.827

2.  Primary thymic carcinoma.

Authors:  Hung-Chang Liu; Wen-Hu Hsu; Yu-Jen Chen; Yu-Jan Chan; Yu-Chung Wu; Biing-Shium Huang; Min-Hsiung Huang
Journal:  Ann Thorac Surg       Date:  2002-04       Impact factor: 4.330

3.  Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma.

Authors:  Yasuko Hosaka; Masanori Tsuchida; Shin-ichi Toyabe; Hajime Umezu; Tadaaki Eimoto; Jun-ichi Hayashi
Journal:  Ann Thorac Surg       Date:  2010-03       Impact factor: 4.330

4.  Thymic carcinoma: current staging does not predict prognosis.

Authors:  D Blumberg; M E Burt; M S Bains; R J Downey; N Martini; V Rusch; R J Ginsberg
Journal:  J Thorac Cardiovasc Surg       Date:  1998-02       Impact factor: 5.209

5.  Chemotherapy for invasive thymoma. A 13-year experience.

Authors:  A Fornasiero; O Daniele; C Ghiotto; M Piazza; L Fiore-Donati; F Calabró; F Rea; M V Fiorentino
Journal:  Cancer       Date:  1991-07-01       Impact factor: 6.860

Review 6.  Tumor-node metastasis staging system for thymic epithelial tumors.

Authors:  Kazuya Kondo
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

7.  Thymic carcinoma. Clinical institutional experience with 15 patients.

Authors:  Shin-ichi Takeda; Noriyoshi Sawabata; Masayoshi Inoue; Masaru Koma; Hajime Maeda; Hiroshi Hirano
Journal:  Eur J Cardiothorac Surg       Date:  2004-08       Impact factor: 4.191

Review 8.  Thymoma and thymic carcinoma.

Authors:  Federico Venuta; Marco Anile; Daniele Diso; Domenico Vitolo; Erino A Rendina; Tiziano De Giacomo; Federico Francioni; Giorgio Furio Coloni
Journal:  Eur J Cardiothorac Surg       Date:  2009-07-16       Impact factor: 4.191

9.  Comparison of patterns of relapse in thymic carcinoma and thymoma.

Authors:  James Huang; Nabil P Rizk; William D Travis; Gregory J Riely; Bernard J Park; Manjit S Bains; Joseph Dycoco; Raja M Flores; Robert J Downey; Valerie W Rusch
Journal:  J Thorac Cardiovasc Surg       Date:  2009-07       Impact factor: 5.209

10.  Early Masaoka stage and complete resection is important for prognosis of thymic carcinoma: a 20-year experience at a single institution.

Authors:  Chang Young Lee; Mi Kyung Bae; In Kyu Park; Dae Joon Kim; Jin Gu Lee; Kyung Young Chung
Journal:  Eur J Cardiothorac Surg       Date:  2009-03-25       Impact factor: 4.191

View more
  3 in total

1.  Elevated pretreatment serum lactate dehydrogenase level predicts inferior overall survival and disease-free survival after resection of thymic carcinoma.

Authors:  Qianwen Liu; Xiayu Fu; Xiaodong Su; Xin Wang; Yijun Zhang; Hong Yang; Yi Hu; Jing Wen; Jianhua Fu
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

2.  A Rare Case of Primary Tubular Adenocarcinoma of the Thymus, Enteric Immunophenotype: A Case Study and Review of the Literature.

Authors:  Hae Yoen Jung; Hyundeuk Cho; Jin-Haeng Chung; Sang Byoung Bae; Ji-Hye Lee; Hyun Ju Lee; Si-Hyong Jang; Mee-Hye Oh
Journal:  J Pathol Transl Med       Date:  2015-07-15

3.  Response to chemotherapy with carboplatin plus albumin-bound paclitaxel in a patient with lymphoepithelioma-like thymic carcinoma: A case report.

Authors:  Hiroshi Shima; Hiroaki Ozasa; Takahiro Tsuji; Hitomi Ajimizu; Takashi Nomizo; Yoshitaka Yagi; Yuichi Sakamori; Hiroki Nagai; Sachiko Minamiguchi; Young Hak Kim; Michiaki Mishima
Journal:  Mol Clin Oncol       Date:  2016-03-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.